Skip to main content
logo
Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS · Delayed Price · Currency is USD
23.98
-1.23 (-4.90%)
At close: Oct 15, 2025

Revenue by Product

Millions GBX. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Injectables
1.02B
Log In
Log In
Log In
Log In
Upgrade
Injectables Growth
5.61%
Log In
Log In
Log In
Log In
Upgrade
Generics
802.93M
Log In
Log In
Log In
Log In
Upgrade
Generics Growth
6.52%
Log In
Log In
Log In
Log In
Upgrade
Branded
601.81M
Log In
Log In
Log In
Log In
Upgrade
Branded Growth
4.77%
Log In
Log In
Log In
Log In
Upgrade
Other
20.35M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
20.44%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions GBX. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States
1.48B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
6.35%
Log In
Log In
Log In
Log In
Upgrade
Middle East and North Africa
368.60M
Log In
Log In
Log In
Log In
Upgrade
Middle East and North Africa Growth
25.19%
Log In
Log In
Log In
Log In
Upgrade
Saudi Arabia
235.56M
Log In
Log In
Log In
Log In
Upgrade
Saudi Arabia Growth
12.19%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of the World
170.60M
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of the World Growth
2.95%
Log In
Log In
Log In
Log In
Upgrade
Algeria
166.69M
Log In
Log In
Log In
Log In
Upgrade
Algeria Growth
9.63%
Log In
Log In
Log In
Log In
Upgrade
North America
18.78M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
1.51%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
10.17M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
14.97%
Log In
Log In
Log In
Log In
Upgrade
Egypt
-
Log In
Log In
Log In
Log In
Upgrade
Egypt Growth
-
Log In
Log In
Log In
Log In
Upgrade